Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
INDUSTRY
×
Metastatic Hormone-sensitive Prostate Cancer
×
Androgen Antagonists
×
Clear all
Filters
3
NCT02799602
2025-12-04
ARASENS
Bayer
Phase 3
Completed
1,306 enrolled
25 charts
5 FDA
NCT06498921
2024-10-24
BELBEQA
Bayer
Completed
106 enrolled